BlueSphere Bio's Newly Minted CEO Calls for Urgency on Day One

BlueSphere Bio named a new CEO Tuesday. With ambitions to enter the clinic in the first half of 2023 with its acute myeloid leukemia program, Keir Loiacono, esq., aims to double down on the company’s strengths rather than make any major course corrections.